Indeed, the discovery of GLP‐1 and its receptors has been fundamental for the generation of the most successful drugs to curb obesity, type II diabetes and potentially other metabolic‐related disorders like kidney and cardiovascular disease.16, 17. The gene discussed is GLP1R; the disease is obesity disorder.